[1] |
AFONSO JÚNIOR JE, WEREBE EDE C, CARRARO RM, et al. Lung transplantation[J]. Einstein (Sao Paulo), 2015, 13(2): 297-304. DOI: 10.1590/S1679-45082015RW3156.
|
[2] |
GLORION M, POLARD V, FAVEREAU F, et al. Prevention of ischemia-reperfusion lung injury during static cold preservation by supplementation of standard preservation solution with HEMO2life® in pig lung transplantation model[J]. Artif Cells Nanomed Biotechnol, 2018, 46(8): 1773-1780. DOI: 10.1080/21691401.2017.1392315.
|
[3] |
CHAN JCY, CHABAN R, CHANG SH, et al. Future of lung transplantation: xenotransplantation and bioengineering lungs[J]. Clin Chest Med, 2023, 44(1): 201-214. DOI: 10.1016/j.ccm.2022.11.003.
|
[4] |
JIANG T, YANG W, ZHANG H, et al. Hydrogen sulfide ameliorates lung ischemia-reperfusion injury through SIRT1 signaling pathway in type 2 diabetic rats[J]. Front Physiol, 2020, 11: 596. DOI: 10.3389/fphys.2020.00596.
|
[5] |
CAPUZZIMATI M, HOUGH O, LIU M. Cell death and ischemia-reperfusion injury in lung transplantation[J]. J Heart Lung Transplant, 2022, 41(8): 1003-1013. DOI: 10.1016/j.healun.2022.05.013.
|
[6] |
ALMEIDA FM, BATTOCHIO AS, NAPOLI JP, et al. Creatine supply attenuates ischemia-reperfusion injury in lung transplantation in rats[J]. Nutrients, 2020, 12(9): 2765. DOI: 10.3390/nu12092765.
|
[7] |
TEIJEIRO-PARADIS R, CYPEL M, DEL SORBO L. Protective mechanical ventilation in organ donors: a lifesaving maneuver[J]. Am J Respir Crit Care Med, 2020, 202(2): 167-169. DOI: 10.1164/rccm.202005-1559ED.
|
[8] |
STARKE H, VON DOSSOW V, KARSTEN J. Intraoperative circulatory support in lung transplantation: current trend and its evidence[J]. Life (Basel), 2022, 12(7): 1005. DOI: 10.3390/life12071005.
|
[9] |
VLASTOS D, ZEINAH M, NINKOVIC-HALL G, et al. The effects of ischaemic conditioning on lung ischaemia-reperfusion injury[J]. Respir Res, 2022, 23(1): 351. DOI: 10.1186/s12931-022-02288-z.
|
[10] |
AVTAAR SINGH SS, DAS DE S, AL-ADHAMI A, et al. Primary graft dysfunction following lung transplantation: from pathogenesis to future frontiers[J]. World J Transplant, 2023, 13(3): 58-85. DOI: 10.5500/wjt.v13.i3.58.
|
[11] |
ZOGG H, SINGH R, RO S. Current advances in RNA therapeutics for human diseases[J]. Int J Mol Sci, 2022, 23(5): 2736. DOI: 10.3390/ijms23052736.
|
[12] |
ALA U. Competing endogenous RNAs, non-coding RNAs and diseases: an intertwined story[J]. Cells, 2020, 9(7): 1574. DOI: 10.3390/cells9071574.
|
[13] |
LIU X, ZHANG Y, ZHOU S, et al. Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines[J]. J Control Release, 2022, 348: 84-94. DOI: 10.1016/j.jconrel.2022.05.043.
|
[14] |
CHEN L, WANG C, SUN H, et al. The bioinformatics toolbox for circRNA discovery and analysis[J]. Brief Bioinform, 2021, 22(2): 1706-1728. DOI: 10.1093/bib/bbaa001.
|
[15] |
ZHAO M, FENG J, TANG L. Competing endogenous RNAs in lung cancer[J]. Cancer Biol Med, 2021, 18(1): 1-20. DOI: 10.20892/j.issn.2095-3941.2020.0203.
|
[16] |
JANG J, HWANG I, JUNG I. TimesVector-Web: a web service for analysing time course transcriptome data with multiple conditions[J]. Genes (Basel), 2021, 13(1): 73. DOI: 10.3390/genes13010073.
|
[17] |
HUANG DW, SHERMAN BT, TAN Q, et al. The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists[J]. Genome Biol, 2007, 8(9): R183. DOI: 10.1186/gb-2007-8-9-r183.
|
[18] |
SZKLARCZYK D, GABLE AL, NASTOU KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets[J]. Nucleic Acids Res, 2021, 49(D1): D605-D612. DOI: 10.1093/nar/gkaa1074.
|
[19] |
LIU X, HONG Z, LIU J, et al. Computational methods for identifying the critical nodes in biological networks[J]. Brief Bioinform, 2020, 21(2): 486-497. DOI: 10.1093/bib/bbz011.
|
[20] |
ROBIN X, TURCK N, HAINARD A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves[J]. BMC Bioinformatics, 2011, 12: 77. DOI: 10.1186/1471-2105-12-77.
|
[21] |
焦国慧, 王梓涛, 陈静瑜. 肺移植全球发展概况与展望[J]. 器官移植, 2022, 13(4): 417-424. DOI: 10.3969/j.issn.1674-7445.2022.04.002.JIAO GH, WANG ZT, CHEN JY. Current status and prospect of global development of lung transplantation[J]. Organ Transplant, 2022, 13(4): 417-424. DOI: 10.3969/j.issn.1674-7445.2022.04.002.
|
[22] |
CHEN-YOSHIKAWA TF. Ischemia-reperfusion injury in lung transplantation[J]. Cells, 2021, 10(6): 1333. DOI: 10.3390/cells10061333.
|
[23] |
王净, 胡春兰, 于慧智, 等. 肺移植期间肺缺血再灌注损伤及药物治疗的研究进展[J]. 东南大学学报(医学版), 2022, 41(4): 578-582. DOI: 10.3969/j.issn.1671-6264.2022.04.021.WANG J, HU CL, YU HZ, et al. Research progress on pulmonary ischemia-reperfusion injury and drug therapy during lung transplantation[J]. J Southeast Univ (Med Sci Edit), 2022, 41(4): 578-582. DOI: 10.3969/j.issn.1671-6264.2022.04.021.
|
[24] |
AKBARPOUR M, LECUONA E, CHIU SF, et al. Residual endotoxin induces primary graft dysfunction through ischemia/reperfusion-primed alveolar macrophages[J]. J Clin Invest, 2020, 130(8): 4456-4469. DOI: 10.1172/JCI135838.
|
[25] |
GAO W, JIANG T, LIU YH, et al. Endothelial progenitor cells attenuate the lung ischemia/reperfusion injury following lung transplantation via the endothelial nitric oxide synthase pathway[J]. J Thorac Cardiovasc Surg, 2019, 157(2): 803-814. DOI: 10.1016/j.jtcvs.2018.08.092.
|
[26] |
祝卿, 周文琴, 万里, 等. 1-磷酸鞘氨醇及受体1在小鼠肺缺血再灌注损伤中的表达变化和意义[J]. 四川大学学报(医学版), 2018, 49(6): 891-894.ZHU Q, ZHOU WQ, WAN L, et al. The expression of sphingosine-1-phosphate and sphingosine-1-phosphate receptor 1 in mouse model of pulmonary ischemia-reperfusion injury[J]. J Sichuan Univ (Med Sci), 2018, 49(6): 891-894.
|
[27] |
XING D, HAGE FG, FENG W, et al. Endothelial cells overexpressing CXCR1/2 are renoprotective in rats with acute kidney injury[J]. Am J Physiol Renal Physiol, 2023, 324(4): F374-F386. DOI: 10.1152/ajprenal.00238.2022.
|
[28] |
HSIAO HM, FERNANDEZ R, TANAKA S, et al. Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1β[J]. J Clin Invest, 2018, 128(7): 2833-2847. DOI: 10.1172/JCI98436.
|
[29] |
WANG F, WANG F, LI F, et al. Methane attenuates lung ischemia-reperfusion injury via regulating PI3K-Akt-NFκB signaling pathway[J]. J Recept Signal Transduct Res, 2020, 40(3): 209-217. DOI: 10.1080/10799893.2020.1727925.
|
[30] |
GENDY AM, AMIN MM, AL-MOKADDEM AK, et al. Cilostazol mitigates mesenteric ischemia/reperfusion-induced lung lesion: contribution of PPAR-γ, NF-κB, and STAT3 crosstalk[J]. Life Sci, 2021, 266: 118882. DOI: 10.1016/j.lfs.2020.118882.
|
[31] |
DAI SH, CHEN LJ, QI WH, et al. microRNA-145 inhibition upregulates SIRT1 and attenuates autophagy in a mouse model of lung ischemia/reperfusion injury via NF-κB-dependent Beclin 1[J]. Transplantation, 2021, 105(3): 529-539. DOI: 10.1097/TP.0000000000003435.
|
[32] |
WATANABE T, MARTINU T, CHRUSCINSKI A, et al. A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice[J]. Am J Transplant, 2019, 19(12): 3377-3389. DOI: 10.1111/ajt.15550.
|
[33] |
CHEN D, CHEN C, XIAO X, et al. TNF-α induces neutrophil apoptosis delay and promotes intestinal ischemia-reperfusion-induced lung injury through activating JNK/FoxO3a pathway[J]. Oxid Med Cell Longev, 2021: 8302831. DOI: 10.1155/2021/8302831.
|
[34] |
LU Y, WANG YL, LIU Q, et al. MiRNA-122 promotes ischemia-reperfusion injury after lung transplantation via the toll-like receptor signaling pathway[J]. Curr Med Sci, 2021, 41(6): 1231-1238. DOI: 10.1007/s11596-021-2487-y.
|
[35] |
JIN H, ZHANG C, SUN C, et al. OX40 expression in neutrophils promotes hepatic ischemia/reperfusion injury[J]. JCI Insight, 2019, 4(21): e129736. DOI: 10.1172/jci.insight.129736.
|
[36] |
ZHOU H, SHI C, HU S, et al. BI1 is associated with microvascular protection in cardiac ischemia reperfusion injury via repressing Syk-Nox2-Drp1-mitochondrial fission pathways[J]. Angiogenesis, 2018, 21(3): 599-615. DOI: 10.1007/s10456-018-9611-z.
|
[37] |
YANG CC, SUNG PH, CHEN CH, et al. Additional benefit of induced pluripotent stem cell-derived mesenchymal stem cell therapy on sepsis syndrome-associated acute kidney injury in rat treated with antibiotic[J]. Stem Cell Res Ther, 2021, 12(1): 526. DOI: 10.1186/s13287-021-02582-5.
|
[38] |
MARTÍNEZ-LÓPEZ M, IBORRA S, CONDE-GARROSA R, et al. Microbiota sensing by Mincle-Syk axis in dendritic cells regulates interleukin-17 and -22 production and promotes intestinal barrier integrity[J]. Immunity, 2019, 50(2): 446-461. DOI: 10.1016/j.immuni.2018.12.020.
|
[39] |
LI C, XUE VW, WANG QM, et al. The Mincle/Syk/NF-κB signaling circuit is essential for maintaining the protumoral activities of tumor-associated macrophages[J]. Cancer Immunol Res, 2020, 8(8): 1004-1017. DOI: 10.1158/2326-6066.CIR-19-0782.
|
[40] |
SADRAS T, MARTIN M, KUME K, et al. Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer[J]. Mol Cell, 2021, 81(10): 2094-2111. DOI: 10.1016/j.molcel.2021.03.043.
|
[41] |
HUFFAKER TB, EKIZ HA, BARBA C, et al. A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages[J]. Nat Commun, 2021, 12(1): 2620. DOI: 10.1038/s41467-021-22923-5.
|
[42] |
YANG L, CHEN S, ZHAO Q, et al. Histone deacetylase 3 contributes to the antiviral innate immunity of macrophages by interacting with FOXK1 to regulate STAT1/2 transcription[J]. Cell Rep, 2022, 38(4): 110302. DOI: 10.1016/j.celrep.2022.110302.
|
[43] |
UZHACHENKO RV, SHANKER A. CD8+T lymphocyte and NK cell network: circuitry in the cytotoxic domain of immunity[J]. Front Immunol, 2019, 10: 1906. DOI: 10.3389/fimmu.2019.01906.
|
[44] |
NIEDERLOVA V, TSYKLAURI O, CHADIMOVA T, et al. CD8+Tregs revisited: a heterogeneous population with different phenotypes and properties[J]. Eur J Immunol, 2021, 51(3): 512-530. DOI: 10.1002/eji.202048614.
|
[45] |
MA K, QIAO Y, WANG H, et al. Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma[J]. Ann Transl Med, 2020, 8(22): 1478. DOI: 10.21037/atm-20-6486.
|
[46] |
HE L, WANG Z, ZHOU R, et al. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway[J]. Biomed Pharmacother, 2021, 133: 110993. DOI: 10.1016/j.biopha.2020.110993.
|
[47] |
HE X, ZHENG Y, LIU S, et al. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway[J]. J Cell Physiol, 2018, 233(3): 2476-2488. DOI: 10.1002/jcp.26124.
|
[48] |
YANG Y, LI L. Depleting microRNA-146a-3p attenuates lipopolysaccharide-induced acute lung injury via up-regulating SIRT1 and mediating NF-κB pathway[J]. J Drug Target, 2021, 29(4): 420-429. DOI: 10.1080/1061186X.2020.1850738.
|
[49] |
NONG Y, GUO Y, GUMPERT A, et al. Single dose of synthetic microRNA-199a or microRNA-149 mimic does not improve cardiac function in a murine model of myocardial infarction[J]. Mol Cell Biochem, 2021, 476(11): 4093-4106. DOI: 10.1007/s11010-021-04227-w.
|
[50] |
CHEN F, HAN J, WANG D. Identification of key microRNAs and the underlying molecular mechanism in spinal cord ischemia-reperfusion injury in rats[J]. PeerJ, 2021, 9: e11454. DOI: 10.7717/peerj.11454.
|
[51] |
XU N, HE D, SHAO Y, et al. Lung-derived exosomes in phosgene-induced acute lung injury regulate the functions of mesenchymal stem cells partially via miR-28-5p[J]. Biomed Pharmacother, 2020, 121: 109603. DOI: 10.1016/j.biopha.2019.109603.
|
[52] |
YU Z, ZHU M, SHU D, et al. LncRNA PEG11as aggravates cerebral ischemia/reperfusion injury after ischemic stroke through miR-342-5p/PFN1 axis[J]. Life Sci, 2023, 313: 121276. DOI: 10.1016/j.lfs.2022.121276.
|
[53] |
CHEN W, LI S, LIU Q, et al. MicroRNA-342-5p protects against myocardial ischemia-reperfusion injury by targeting the GPRC5A pathway[J]. Pharmazie, 2020, 75(6): 271-274. DOI: 10.1691/ph.2020.0383.
|
[54] |
LIU W, HU C, ZHANG B, et al. Exosomal microRNA-342-5p secreted from adipose-derived mesenchymal stem cells mitigates acute kidney injury in sepsis mice by inhibiting TLR9[J]. Biol Proced Online, 2023, 25(1): 10. DOI: 10.1186/s12575-023-00198-y.
|
[55] |
MA J, LI YT, ZHANG SX, et al. MiR-590-3p attenuates acute kidney injury by inhibiting tumor necrosis factor receptor-associated factor 6 in septic mice[J]. Inflammation, 2019, 42(2): 637-649. DOI: 10.1007/s10753-018-0921-5.
|
[56] |
WEI X, YI X, LV H, et al. MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy[J]. Cell Death Dis, 2020, 1(8): 657. DOI: 10.1038/s41419-020-02857-4.
|
[57] |
HUANG T, GAO Y, CAO Y, et al. Downregulation of mmu_circ_0000943 ameliorates renal ischemia reperfusion-triggered inflammation and oxidative stress via regulating mmu-miR-377-3p/Egr2 axis[J]. Int Immunopharmacol, 2022, 106: 108614. DOI: 10.1016/j.intimp.2022.108614.
|
[58] |
WANG Y, JIN F, HUANG L, et al. MiR-590-3p protects against ischaemia/reperfusion injury in an oxygen-glucose deprivation and reoxygenation cellular model by regulating HMGB1/TLR4/MyD88/NF-κB signaling[J]. Histol Histopathol, 2023, 38(8): 941-951. DOI: 10.14670/HH-18-562.
|
[59] |
LEON-CORIA A, KUMAR M, WORKENTINE M, et al. Muc2 mucin and nonmucin microbiota confer distinct innate host defense in disease susceptibility and colonic injury[J]. Cell Mol Gastroenterol Hepatol, 2021, 11(1): 77-98. DOI: 10.1016/j.jcmgh.2020.07.003.
|
[60] |
WANG P, BAO W, LIU X, et al. LncRNA miR143HG inhibits the proliferation of glioblastoma cells by sponging miR-504[J]. Int J Neurosci, 2022, 132(11): 1137-1142. DOI: 10.1080/00207454.2020.1865950.
|